Pulmonx (LUNG) Cash from Investing Activities (QoQ) (2020 - 2025)
Powered by 
Analysis
Pulmonx (LUNG) Cash from Investing Activities (QoQ) (2020 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.08 Bn | 174.48 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.86 Bn | 122.64 Bn | 1.96 Bn |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn |
| 4 | Stryker | 103.82 Bn | 100.34 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn |
| 7 | Alcon | 32.95 Bn | 31.49 Bn | 1.68 Bn |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn |
| 10 | Pulmonx | 76.96 Mn | 7.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 59.22% |
| Jun 30, 2025 | -66.46% |
| Mar 31, 2025 | 15.97% |
| Dec 31, 2024 | 108.37% |
| Sep 30, 2024 | 908.50% |
| Jun 30, 2024 | 66.69% |
| Mar 31, 2024 | 9.00% |
| Dec 31, 2023 | -379.13% |
| Sep 30, 2023 | 221.40% |
| Jun 30, 2023 | -241.64% |
| Mar 31, 2023 | 178.95% |
| Dec 31, 2022 | -1,752.27% |
| Sep 30, 2022 | -97.88% |
| Jun 30, 2022 | 137.00% |
| Mar 31, 2022 | 80.70% |
| Dec 31, 2021 | -753.08% |
| Sep 30, 2021 | -187.86% |
| Jun 30, 2021 | 90.54% |
| Mar 31, 2021 | -1,708.23% |
| Dec 31, 2020 | -811.84% |